Literature DB >> 18460803

Characterization and bioavailability of liposomes containing a ukon extract.

Makoto Takahashi1, Dai Kitamoto, Tomohiro Imura, Hirosuke Oku, Kensaku Takara, Koji Wada.   

Abstract

In order to use liposomes as an efficient carrier of functional food materials, liposomes encapsulating a ukon extract (LUE) were prepared by the mechanochemical method under different conditions, and were physico-chemically and biochemically characterized. After a homogenization treatment, the size of LUE decreased with decreasing concentration of the extract from 10 to 2.5 wt %, but did not decrease below 570 nm. LUE were thus subjected to microfluidization. The LUE solutions obtained from less than 5 wt % of the extract remained well dispersed for at least 14 d, whereas those from 10 wt % showed phase separation. With 5 wt % of the extract, the size of LUE obtained at an inlet pressure of 100 MPa was smaller than that obtained at 20 MPa, and reached below 180 nm. Under optimal conditions, resulting LUE was confirmed to be small unilamellar vesicles (SUV) with a diameter of approximately 100 nm by freeze-fracture electron microscopy (FFEM). When used for treating simulated gastric and intestinal fluids, LUE obtained by microfluidization showed a 2-fold higher residual rate of curcumin than the uncapsuled extract itself. The bioactivity of LUE was further examined for its suppressive effect on carbon tetrachloride (CCl(4))-induced liver injury by using mice. Orally administrated LUE at a dose of 10 mg/kg as the extract had a much higher suppressive effect on the serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, compared to the uncapsuled extract at a dose of 33 mg/kg.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460803     DOI: 10.1271/bbb.70659

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  6 in total

1.  Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.

Authors:  Vivek R Yadav; Sahdeo Prasad; Ramaswamy Kannappan; Jayaraj Ravindran; Madan M Chaturvedi; Lauri Vaahtera; Jaakko Parkkinen; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 2.  Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer.

Authors:  Hareesh B Nair; Bokyung Sung; Vivek R Yadav; Ramaswamy Kannappan; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-07-21       Impact factor: 5.858

3.  Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.

Authors:  Preetha Anand; Hareesh B Nair; Bokyung Sung; Ajaikumar B Kunnumakkara; Vivek R Yadav; Rajeshwar R Tekmal; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2009-09-06       Impact factor: 5.858

4.  Curcumin liposomes interfere with quorum sensing system of Aeromonas sobria and in silico analysis.

Authors:  Ting Ding; Tingting Li; Zhi Wang; Jianrong Li
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

5.  A hot water extract of turmeric (Curcuma longa) suppresses acute ethanol-induced liver injury in mice by inhibiting hepatic oxidative stress and inflammatory cytokine production.

Authors:  Ryusei Uchio; Yohei Higashi; Yusuke Kohama; Kengo Kawasaki; Takashi Hirao; Koutarou Muroyama; Shinji Murosaki
Journal:  J Nutr Sci       Date:  2017-01-12

Review 6.  Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments.

Authors:  Palanivel Ganesan; Govindarajan Karthivashan; Shin Young Park; Joonsoo Kim; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2018-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.